PICC

Linear Health Sciences Announces Expanded Indication for Orchid Safety Release Valve

Retrieved on: 
Tuesday, October 17, 2023

Medical device company Linear Health Sciences today announced it received an expanded indication from the U.S. Food & Drug Administration (FDA) for its Orchid SRV ™ safety release valve.

Key Points: 
  • Medical device company Linear Health Sciences today announced it received an expanded indication from the U.S. Food & Drug Administration (FDA) for its Orchid SRV ™ safety release valve.
  • The expanded indication means that the Orchid SRV may now be used with all IV access methods.
  • View the full release here: https://www.businesswire.com/news/home/20231017804593/en/
    Linear Health Sciences' Orchid SRV is a sterile, single-use connector for needle-free access that, when activated, makes return to treatment fast, simple, and clean, while improving both the patient and clinician experience.
  • Qualified clinical evaluations of the Orchid SRV will continually quantify device utilization, driving Linear Health Science’s next generations of innovation.

Access Vascular Highlights New Bacterial Adhesion Data at AVA 2023

Retrieved on: 
Tuesday, October 17, 2023

Access Vascular, Inc. (AVI) , a company addressing the most common and costly vascular access complications with its advanced biomaterial platform, today announced findings from a new, in vitro study showing a significant reduction in bacterial adhesion and thrombus accumulation in peripherally inserted central catheters (PICC) and midline catheters with AVI’s MIMIX™ hydrophilic biomaterial (HBM).

Key Points: 
  • Access Vascular, Inc. (AVI) , a company addressing the most common and costly vascular access complications with its advanced biomaterial platform, today announced findings from a new, in vitro study showing a significant reduction in bacterial adhesion and thrombus accumulation in peripherally inserted central catheters (PICC) and midline catheters with AVI’s MIMIX™ hydrophilic biomaterial (HBM).
  • The HBM demonstrated a 99.998 percent reduction in bacterial adhesion compared with the standard polyurethane catheter, and a 99.989 percent reduction compared with an augmented polyurethane material.
  • These findings are consistent with previously reported in vitro data on thrombus accumulation, based on platelet count,iv,v with the HBM catheter.
  • “These results highlight the potential for catheters made from MIMIX™ to reduce bacterial adhesion, which often leads to central-line associated bloodstream infections (CLABSI) and has devastating implications for already sick patients,” said James Biggins, CEO of Access Vascular.

NaaS Technology Inc. Joins NASDAQ Golden Dragon China Index, One of Nine Among New Energy Companies

Retrieved on: 
Monday, September 18, 2023

BEIJING, Sept. 18, 2023 /PRNewswire/ -- NaaS Technology Inc. (Nasdaq: NAAS), the first U.S. listed EV charging service company in China, today announced its inclusion in the NASDAQ Golden Dragon China Index, making it one of nine new energy companies and the only EV charging service company to be part of this index.

Key Points: 
  • BEIJING, Sept. 18, 2023 /PRNewswire/ -- NaaS Technology Inc. (Nasdaq: NAAS), the first U.S. listed EV charging service company in China, today announced its inclusion in the NASDAQ Golden Dragon China Index, making it one of nine new energy companies and the only EV charging service company to be part of this index.
  • The NASDAQ Golden Dragon China Index is widely recognized as a critical gauge for evaluating the performance of Chinese enterprises in the U.S. stock market.
  • It covers a diverse range of sectors, encompassing digital, technology, new forms of consumption, and clean energy, featuring renowned companies in the internet space and the new energy sector, among others.
  • NaaS' inclusion enriches the NASDAQ Golden Dragon China Index and brings fresh vigor to the new energy sector with its charging services.

NaaS Debuts at the 20th China-ASEAN Expo to Showcase Pioneer Services for Global Energy Market

Retrieved on: 
Sunday, September 17, 2023

NaaS Technology Inc. (NASDAQ: NAAS), a leading EV charging service provider, is poised to make its premiere at the event, and are set to showcase their innovative products and energy digitalization solutions at the expo.

Key Points: 
  • NaaS Technology Inc. (NASDAQ: NAAS), a leading EV charging service provider, is poised to make its premiere at the event, and are set to showcase their innovative products and energy digitalization solutions at the expo.
  • In the process of energy transition, the new energy industry stands as the frontier of globalization-a theme that resonates worldwide.
  • The huge market potential has attracted heightened attention from an expanding array of global stakeholders, where NaaS seizes this opportunity well and makes prominent proceeds.
  • The partnerships will bring out collaboration in charging infrastructure construction as well as digital and intelligent application of new energy.

Teleflex Selected to Exhibit Arrow™ VPS Rhythm™ DLX Device and Arrow™ PICCs preloaded with the NaviCurve™ Stylet at Vizient Innovative Technology Exchange

Retrieved on: 
Friday, September 15, 2023

WAYNE, Pa., Sept. 15, 2023 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced it has been selected to exhibit Arrow™ VPS Rhythm™ DLX Device and Arrow™ PICCs preloaded with the NaviCurve™ Stylet at the Vizient Innovative Technology Exchange.

Key Points: 
  • WAYNE, Pa., Sept. 15, 2023 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced it has been selected to exhibit Arrow™ VPS Rhythm™ DLX Device and Arrow™ PICCs preloaded with the NaviCurve™ Stylet at the Vizient Innovative Technology Exchange.
  • Vizient, Inc ., the nation’s largest provider-driven healthcare performance improvement company, will hold the Exchange on Oct. 3 in Grapevine, Texas.
  • The VPS Rhythm™ DLX Device and NaviCurve™ Stylet are engineered to work together to give Vascular Access Specialists more efficient and predictable PICC placement.
  • This device works in concert with the Arrow™ PICC preloaded with the NaviCurve™ Stylet, providing innovative tip navigation/location technologies.

NaaS Records 132% YoY Revenue Growth and 112% YoY Increase of Charging Volume reaching 2,251 GWh in H1 2023

Retrieved on: 
Friday, September 8, 2023

Charging volume transacted through NaaS’ network reached 1,228 GWh in the second quarter of 2023 and 2,251 GWh in the first half of 2023, representing an increase of 112% and 112% year over year, respectively.

Key Points: 
  • Charging volume transacted through NaaS’ network reached 1,228 GWh in the second quarter of 2023 and 2,251 GWh in the first half of 2023, representing an increase of 112% and 112% year over year, respectively.
  • Non-IFRS net loss attributable to ordinary shareholders increased by 12% year over year to RMB108.0 million (US$14.9 million) in the second quarter of 2023.
  • Invesco WilderHill Clean Energy ETF, a subsidiary of global asset management magnate Invesco Ltd., has a large position of NaaS stock.
  • In the second quarter, 53.4% of NaaS' revenue goes to its offline and innovative services, achieving an unprecedented ratio of over 50%.

NaaS Records 132% YoY Revenue Growth and 112% YoY Increase of Charging Volume reaching 2,251 GWh in H1 2023

Retrieved on: 
Friday, September 8, 2023

Charging volume transacted through NaaS' network reached 1,228 GWh in the second quarter of 2023 and 2,251 GWh in the first half of 2023, representing an increase of 112% and 112% year over year, respectively.

Key Points: 
  • Charging volume transacted through NaaS' network reached 1,228 GWh in the second quarter of 2023 and 2,251 GWh in the first half of 2023, representing an increase of 112% and 112% year over year, respectively.
  • Non-IFRS net loss attributable to ordinary shareholders increased by 12% year over year to RMB108.0 million (US$14.9 million) in the second quarter of 2023.
  • Invesco WilderHill Clean Energy ETF, a subsidiary of global asset management magnate Invesco Ltd., has a large position of NaaS stock.
  • In the second quarter, 53.4% of NaaS' revenue goes to its offline and innovative services, achieving an unprecedented ratio of over 50%.

NaaS Technology Inc. Reports Unaudited 2023 Second Quarter and First Half Financial Results

Retrieved on: 
Friday, September 15, 2023

BEIJING, Sept. 8, 2023 /PRNewswire/ -- NaaS Technology Inc. ("NaaS" or the "Company") (Nasdaq: NAAS), the first U.S. listed EV charging service company in China, today announced its unaudited financial results for the second quarter and six months ended June 30, 2023.

Key Points: 
  • BEIJING, Sept. 8, 2023 /PRNewswire/ -- NaaS Technology Inc. ("NaaS" or the "Company") (Nasdaq: NAAS), the first U.S. listed EV charging service company in China, today announced its unaudited financial results for the second quarter and six months ended June 30, 2023.
  • Second Quarter and First Half 2023 Operational Highlights:
    Charging volume transacted through NaaS' network reached 1,228 GWh in the second quarter of 2023 and 2,251 GWh in the first half of 2023, representing an increase of 112% and 112% year over year, respectively.
  • Second Quarter and First Half 2023 Financial Highlights:
    Revenues grew by 121% year over year to RMB48.6 million (US$6.7 million) in the second quarter of 2023 and 132% year over year to RMB84.8 million (US$11.7 million) in the first half of 2023.
  • Second Quarter and First Half 2023 Financial Results:
    Total revenues reached RMB48.6 million (US$6.7 million) in the second quarter of 2023 and RMB84.8 million (US$11.7 million) in the first half of 2023, representing an increase of 121% and 132% year over year, respectively.

Access Vascular Inc. Announces Publication of Study Showing Significantly Reduced Failure Rates with its HydroPICC® Catheter

Retrieved on: 
Tuesday, July 25, 2023

The retrospective study demonstrated that HydroPICC significantly reduced clot formation and failures, compared with conventional polyurethane PICCs.

Key Points: 
  • The retrospective study demonstrated that HydroPICC significantly reduced clot formation and failures, compared with conventional polyurethane PICCs.
  • This retrospective study investigated whether the HydroPICC, constructed of a novel hydrophilic biomaterial with MIMIX™ technology, reduced thrombotic catheter occlusions, compared to polyurethane devices, in 121 patients who received a PICC as part of their medical care.
  • The study results demonstrated no occlusions or replacements in the 60 HydroPICC insertions, while 13 catheter occlusions were reported in the 61 polyurethane insertions catheter group and eight outright PICC replacements (13%).
  • Recently published clinical data for the HydroMID midline catheter showed six-fold failure reduction compared with a standard polyurethane device.

AM Best Affirms Credit Ratings of The People’s Insurance Company of China (Hong Kong), Limited

Retrieved on: 
Wednesday, June 21, 2023

The ratings also reflect the strategic importance of the company to its parent, The People’s Insurance Company (Group) of China Limited (PICC Group) (China), as the sole overseas insurance entity and a key component of PICC Group’s overseas strategies.

Key Points: 
  • The ratings also reflect the strategic importance of the company to its parent, The People’s Insurance Company (Group) of China Limited (PICC Group) (China), as the sole overseas insurance entity and a key component of PICC Group’s overseas strategies.
  • PICC HK underwrites direct onshore general insurance in Hong Kong and inward reinsurance from mainland China and other geographic regions.
  • For additional information regarding the use and limitations of Credit Rating opinions, please view Guide to Best’s Credit Ratings .
  • AM Best is a global credit rating agency, news publisher and data analytics provider specialising in the insurance industry.